1. Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells.
- Author
-
Goldstein S, Elkins WR, London WT, Hahn A, Goeken R, Martin JE, and Hirsch VM
- Subjects
- Animals, Cell Line, Enzyme-Linked Immunosorbent Assay, Humans, Macaca mulatta, Simian Acquired Immunodeficiency Syndrome prevention & control, Simian Immunodeficiency Virus growth & development, Time Factors, Viremia immunology, Viremia prevention & control, Antibodies, Viral blood, SAIDS Vaccines immunology, Simian Acquired Immunodeficiency Syndrome immunology, Simian Immunodeficiency Virus immunology
- Abstract
Homologous SIVsm stocks were generated by passage of a macaque isolate of SIVsm (SIVsm/E660) in human CEM x 174 cells or macaque peripheral blood mononuclear cells. Macaques were immunized with whole inactivated SIV vaccine consisting of virus generated by transfection of CEM x 174 cells with the SIVsmH4 clone and were challenged with either cell-free stock. Only vaccinees challenged with virus generated in human cells were protected from infection. This confirms the species-specificity of whole inactivated vaccine-mediated protection.
- Published
- 1994
- Full Text
- View/download PDF